Marina Antoch, PhD

"Marina Antoch"
Mean distance: 17.3 (cluster 31)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Khapre RV, Patel SA, Kondratova AA, et al. (2014) Metabolic clock generates nutrient anticipation rhythms in mTOR signaling. Aging. 6: 675-89
Comas M, Kuropatwinski KK, Wrobel M, et al. (2014) Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice. Chronobiology International. 31: 901-10
Casey TM, Crodian J, Erickson E, et al. (2014) Tissue-specific changes in molecular clocks during the transition from pregnancy to lactation in mice. Biology of Reproduction. 90: 127
Khapre RV, Kondratova AA, Patel S, et al. (2014) BMAL1-dependent regulation of the mTOR signaling pathway delays aging. Aging. 6: 48-57
Antoch MP, Toshkov I, Kuropatwinski KK, et al. (2013) Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis. Cell Cycle (Georgetown, Tex.). 12: 3673-80
Antoch MP, Kondratov RV. (2013) Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapy. Handbook of Experimental Pharmacology. 289-309
Komarova EA, Antoch MP, Novototskaya LR, et al. (2012) Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging. 4: 709-14
Comas M, Toshkov I, Kuropatwinski KK, et al. (2012) New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis. Aging. 4: 715-22
Spengler ML, Kuropatwinski KK, Comas M, et al. (2012) Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America. 109: E2457-65
Hu Y, Spengler ML, Kuropatwinski KK, et al. (2011) Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1. Oncotarget. 2: 1279-90
See more...